NCT04235270View on ClinicalTrials.gov

A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

January 17, 2020

Primary Completion Date

July 17, 2020

Study Completion Date

July 17, 2020

Conditions
Healthy
Interventions
COMBINATION_PRODUCT

FDC of Macitentan and Tadalafil

Fixed dose combination (FDC) of 1 film-coated tablet containing 10 mg of macitentan and 40 mg of tadalafil will be administered orally.

DRUG

Macitentan

Macitentan 10 mg tablet will be administered orally as free combination.

DRUG

Tadalafil

Tadalafil 40 mg tablet will be administered orally as free combination.

Trial Locations (1)

85283

Celerion, Tempe

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT04235270 - A Study of Macitentan and Tadalafil as a Fixed Dose Combination and the Free Combination in Healthy Adult Participants | Biotech Hunter | Biotech Hunter